来自专业的译者、企业、网页和免费的翻译库。
early breast cancer in the hera trial was limited to operable, primary, invasive adenocarcinoma of the breast, with axillary nodes positive or axillary nodes negative if tumours at least 1 cm in diameter.
hera tyrimo metu ankstyvasis krties vzys tai operuojama pirmin, invazin krties adenokarcinoma, kai pazastini limfmazgi tyrimo rezultatai teigiami arba neigiami ir jei navikai ne mazesnio nei 1 cm diametro.